EpiBiologics

The number of initial public offerings in the US by biopharmaceutical companies in 2023 may be able to at least match the number of IPOs in 2022 now that another company has made its stock market debu

March has been a big month for venture capital mega-rounds of $100m or more and Flare Therapeutics Inc. continued the trend, announcing 22 March that it completed a $123m series B round to fund disc